We interview Joe Healey, CEO and Co-Founder of NanoSyrinx, NanoSyrinx is a discovery-stage synthetic biology biotech developing a novel delivery modality for complex biologics.
We interview Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company.
We interview Sharon Brownlow, Chief Business Officer at the Cell & Gene Therapy Catapult, which is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry.
As we look forward to Pharma Integrates next week, we spoke to this year’s opening speaker Ben Osborn. Ben is the UK Country Manager and Managing Director for Pfizer UK, and the incoming President of the Association of the British Pharmaceutical Industry, giving him a great perspective on the current state of the pharmaceutical and healthcare sectors in the UK.
Integrating bioanalysis with clinical studies and pharmacokinetics: an interview with Stuart McDougall
In this interview Stuart McDougall, Head of Bioanalytical Services at Arcinova (Northumberland, UK), discusses the technologies used to generate fast, reliable data for drug development and how recently Arcinova has been acquired by Quotient Sciences.